Gilead's Leadership in Metastatic Breast Cancer Showcased With New Trodelvy Data at San Antonio Breast Cancer Symposium 2023Business Wire • Thursday
Gilead Sciences, Inc. (GILD) Presents at Piper Sandler 35th Annual Healthcare Conference (Transcript)Seeking Alpha • Wednesday
Gilead Sciences, Inc. (GILD) Presents at 6th Annual Evercore ISI HealthCONx Conference (Transcript)Seeking Alpha • Tuesday
5 Biotech Stocks Likely to Thrive as Industry Prospects Look BrightZacks Investment Research • 11/22/23
Arcellx, A Top 2% Stock, Breaks Out After Inking A $285 Million Deal With GileadInvestors Business Daily • 11/15/23
Gilead Sciences, Inc. (GILD) Jefferies London Healthcare Conference (Transcript)Seeking Alpha • 11/15/23
Arcellx's stock set to surge after Gilead makes $200 million investment at a 30% premiumMarket Watch • 11/15/23